InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.03
(
0.61%
)
US TECH 100
19,700.00
(
-0.02%
)
Dow Jones
42,863.86
(
0.97%
)
Brent Oil
78.70
(
0.00%
)
Bitcoin
62,732.08
(
0.45%
)
Post# of 429503
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dukesking

Send PM Follow Ignore
Followers 26
Posts 3558
Boards Moderated 0
Alias Born 11/12/2018

dukesking

Re: dmiller post# 257158

Saturday, 03/28/2020 12:22:48 PM

Saturday, March 28, 2020 12:22:48 PM

Post# of 429503
Dmiller, Arthritis pain reduction wasn’t one of the primary or secondary endpoints and Vascepa isn’t designed or approved to be prescribed or recommended for hand pain/arthritis. It’s a proven CV Med and if some get real or imagined relief so be it. We are talking about possible CV benefits and potential protection that Vascepa May have against the cardiovascular damage associated with this type of virus. Not a cure for it. I think it’s worth exploring and discussing.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM

CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM

Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM

Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM

Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM

BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!